Literature DB >> 8406690

Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation.

M W Owens1, M B Grisham.   

Abstract

Crohn's disease is an idiopathic, chronic inflammation of the gastrointestinal tract that causes narrowing and stricturing of primarily the small and large intestine. Although the mechanism(s) by which chronic inflammation promotes stricture formation remain to be defined, it does appear to be associated histologically with a hyperplasia of smooth muscle cells and an increased deposition of collagen within the bowel wall. The objective of this study was to assess the effect of two proinflammatory cytokines, tumor necrosis factor and interleukin-1, on the proliferation of human intestinal smooth muscle cells in vitro. Human intestinal smooth muscle cells were seeded at subconfluent densities into 24-well plates in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Human recombinant tumor necrosis factor (0.1-100 ng/ml), interleukin-1 (0.1-500 ng/ml), or control medium (without cytokines) was then added to the cells and incubation continued for 48 or 72 h. Proliferation was determined by the incorporation of tritiated thymidine, added during the final 18 h, into the cellular DNA of the smooth muscle cells. Both cytokines caused a significant dose-dependent increase in intestinal smooth muscle cell proliferation relative to control. These results suggest that the interleukin-1 and tumor necrosis factor produced during chronic inflammation in vivo may enhance the proliferation of smooth muscle cells within the intestinal bowel wall and hence potentially contribute to the narrowing and stricturing of the intestine that is observed in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406690     DOI: 10.1007/bf00916587

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  8 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

Review 2.  Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease.

Authors:  R B Sartor
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Collagen content and types in the intestinal strictures of Crohn's disease.

Authors:  M F Graham; R F Diegelmann; C O Elson; W J Lindblad; N Gotschalk; S Gay; R Gay
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

4.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Collagen synthesis by human intestinal smooth muscle cells in culture.

Authors:  M F Graham; D E Drucker; R F Diegelmann; C O Elson
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

6.  Isolation and culture of human intestinal smooth muscle cells.

Authors:  M F Graham; R F Diegelmann; C O Elson; K N Bitar; H P Ehrlich
Journal:  Proc Soc Exp Biol Med       Date:  1984-09

7.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Authors:  F Cominelli; C C Nast; B D Clark; R Schindler; R Lierena; V E Eysselein; R C Thompson; C A Dinarello
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.

Authors:  K L Isaacs; R B Sartor; S Haskill
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

  8 in total
  8 in total

1.  Colonic muscle enhances the production of interleukin-1 beta messenger RNA in experimental colitis.

Authors:  I Khan; F M al-Awadi
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells.

Authors:  Patricia Garcia; Phyllissa Schmiedlin-Ren; Jason S Mathias; Huaijing Tang; Gregory M Christman; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

3.  Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease.

Authors:  Dario Sorrentino; Claudio Avellini; Carlo Alberto Beltrami; Enrico Pasqual; Ester Zearo
Journal:  Int J Colorectal Dis       Date:  2005-06-11       Impact factor: 2.571

4.  Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell.

Authors:  M G Blennerhassett; F M Bovell; S Lourenssen; K M McHugh
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

Review 5.  Intestinal Anastomotic Healing: What do We Know About Processes Behind Anastomotic Complications.

Authors:  J Rosendorf; M Klicova; I Herrmann; A Anthis; L Cervenkova; R Palek; V Treska; V Liska
Journal:  Front Surg       Date:  2022-06-07

6.  Molecular evidence for two forms of Crohn disease.

Authors:  E C Gilberts; A J Greenstein; P Katsel; N Harpaz; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation.

Authors:  T M Jobson; C K Billington; I P Hall
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation.

Authors:  W E Longo; B Erickson; N Panesar; J E Mazuski; S Robinson; D L Kaminski
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.